Toward noninvasive follow-up of low-risk bladder cancer – Rationale and concept of the UroFollow trial*
Natalya Benderska-Söder, Jan Hovanec, Beate Pesch, Peter J. Goebell, Florian Roghmann, Joachim Noldus, Juri Rabinovich, Katharina Wichert, Jan Gleichenhagen, Heiko U. Käfferlein, Christina Köhler, Georg Johnen, Karoline Kernig, Oliver W. Hakenberg, Daniela Jahn, Tilman Todenhöfer, Arnulf Stenzl, Jochen Gleißner, Klaus Gerwert, Samir F. El‐Mashtoly, Thomas Behrens, Thomas Brüning, Bernd J. Schmitz‐Dräger
Topics & Concepts
OverdiagnosisMedicineBladder cancerCystoscopyProspective cohort studyUrine cytologyRandomized controlled trialUrineUrinary systemSurrogate endpointInternal medicineCancerOncologyUrologyTumor markerBladder and Urothelial Cancer TreatmentsUrinary and Genital Oncology StudiesFerroptosis and cancer prognosis